Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Evidence for novel cannabinoid receptors.

Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, Liu J, Kunos G.

Pharmacol Ther. 2005 May;106(2):133-45. Epub 2005 Jan 11. Review.

PMID:
15866316
2.

Pharmacological actions of cannabinoids.

Pertwee RG.

Handb Exp Pharmacol. 2005;(168):1-51. Review.

PMID:
16596770
3.

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.

Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.

Brain Res Mol Brain Res. 2004 Dec 6;132(1):87-92.

PMID:
15548432
4.
5.

[Pharmacology of cannabinoid receptors].

Le Fur G, Rinaldi-Carmona M, Barth F, Alexander J.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):933-8; discussion 938-40. French.

PMID:
18225447
6.

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41.

7.

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.

Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Ségui M, Casellas P.

FEBS Lett. 1998 Apr 3;425(3):419-25.

8.

Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.

Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, Deng H, Makriyannis A, Dey SK.

Biol Reprod. 1998 Jun;58(6):1490-5.

PMID:
9623610
9.

Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.

Alhamoruni A, Lee AC, Wright KL, Larvin M, O'Sullivan SE.

J Pharmacol Exp Ther. 2010 Oct;335(1):92-102. doi: 10.1124/jpet.110.168237. Epub 2010 Jun 30.

10.

Cannabinoid modulation of perivascular sympathetic and sensory neurotransmission.

Ralevic V, Kendall DA.

Curr Vasc Pharmacol. 2009 Jan;7(1):15-25. Review.

PMID:
19149636
11.

Cardiovascular actions of cannabinoids and their generation during shock.

Wagner JA, Varga K, Kunos G.

J Mol Med (Berl). 1998 Nov-Dec;76(12):824-36. Review.

PMID:
9846953
12.

Role of cannabinoid receptor in the brain as it relates to drug reward.

Yamamoto T, Takada K.

Jpn J Pharmacol. 2000 Nov;84(3):229-36. Review.

13.

Novel cannabinoid receptors.

Brown AJ.

Br J Pharmacol. 2007 Nov;152(5):567-75. Epub 2007 Oct 1. Review.

14.

Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.

Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM.

Br J Pharmacol. 2004 May;142(2):257-66.

15.
16.

Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

Pertwee RG.

Life Sci. 2005 Feb 4;76(12):1307-24. Epub 2004 Dec 8. Review.

PMID:
15670612
18.

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.

Sharkey KA, Cristino L, Oland LD, Van Sickle MD, Starowicz K, Pittman QJ, Guglielmotti V, Davison JS, Di Marzo V.

Eur J Neurosci. 2007 May;25(9):2773-82. Epub 2007 Apr 25.

PMID:
17459108
19.

Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.

Mulè F, Amato A, Baldassano S, Serio R.

Pharmacol Res. 2007 Sep;56(3):185-92. Epub 2007 Jun 21.

PMID:
17656103
20.

Behavioral effects of cannabinoid agents in animals.

Chaperon F, Thiébot MH.

Crit Rev Neurobiol. 1999;13(3):243-81. Review.

PMID:
10803637

Supplemental Content

Support Center